Phase III, Remdesivir (GS-5734) in severe COVID-19 participants
Clinical Trial Grant
Administered By
Medicine, Infectious Diseases
Awarded By
Gilead Sciences, Inc.
Start Date
March 31, 2020
End Date
March 31, 2021
Administered By
Medicine, Infectious Diseases
Awarded By
Gilead Sciences, Inc.
Start Date
March 31, 2020
End Date
March 31, 2021